Dependence of murine obstructive airway disease on CD40 ligand

Transplantation

Volumn 72, Issue 10, 2001, Pages 1616-1625

  Rumbley, Catherine A ^a,b   Silver, Scott J ^a   Michael Phillips, S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD40 ANTIGEN; GLYCOPROTEIN GP 39;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BASEMENT MEMBRANE; CELL INFILTRATION; CONTROLLED STUDY; EXPERIMENTAL MODEL; EXPLANT; FIBROSIS; GRAFT REJECTION; HISTOPATHOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; OBSTRUCTIVE AIRWAY DISEASE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TRACHEA GRAFT;

EID: 0035960617     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200111270-00007     Document Type: Article

References (48)

1. The first transplantation of the lung in a human revisited
2. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation
3. Bronchiolitis obliterans
4. Bronchiolitis obliterans after lung transplantation: A review
5. Bronchoalveolar lavage, histological and immunohistochemical features in cryptogenic organizing pneumonia
6. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group
7. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans
8. Tests of airway function in detecting and monitoring treatment of obliterative bronchiolitis after lung transplantation
9. Obliterative bronchiolitis after heart-lung transplantation: Apparent arrest by augmented immunosuppression
10. Lung transplantation
11. Recurrence of obliterative bronchiolitis and determinants of outcome in 139 pulmonary retransplant recipients
12. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management
13. Bronchiolitis obliterans syndrome: Incidence, natural history, prognosis, and risk factors
14. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation
15. Are multiple immunopathogenetic events occurring during the development of obliterative bronchiolitis and acute rejection?
16. Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations
17. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome
18. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation
19. T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas
20. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways
21. Hierarchical control of lymphocyte survival
22. Bax-independent inhibition of apoptosis by Bcl-XL
23. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL
24. A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes
25. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model
26. CD40-CD40 ligand
27. The CD40 pathway in allograft rejection, acceptance, and tolerance
28. Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade
29. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways
30. Prolonged anti-CD40 ligand therapy improves primate cardiac allograft survival
31. Prolongation of primate cardiac allograft survival by treatment with anti-CD40 ligand (CD154) antibody
32. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival
33. Architectural remodeling of lung allografts in acute and chronic rejection
34. Bronchiolar basement membrane changes associated with bronchiolitis obliterans in lung allografts: A retrospective study of serial transbronchial biopsies with immunohistochemistry [corrected] [published erratum appears in Mod Pathol 1996; 9: 803]
35. The future of organ and tissue transplantation: Can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection?
36. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells
37. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies
38. Blockade of T cell costimulation prevents development of experimental chronic renal allograft rejection
39. T cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo
40. What's new in transplant immunology: Problems and prospects
41. Survival of mouse pancreatic islet cell allografts in recipients treated with allogeneic small lymphocytes and antibodies to CD40 ligand
42. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection
43. Blocking the CD28-B7 T-cell costimulatory pathway abrogates the development of obliterative bronchiolitis in a murine heterotopic airway model
44. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts
45. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment
46. The roles of CD28 and CD40 Ligand in T cell activation and tolerance
47. Immune cells in a mouse airway model of obliterative bronchiolitis